by $1.94, the closing share price the day immediately preceding the grant date, March 28, 2024 in this case. Mr. Shepro received 50,195 shares of common stock in lieu of $71,277 for the second quarter of 2024. The Adjustment was determined by dividing the amount of the forgone cash compensation by $1.42, the closing share price the day immediately preceding the grant date, June 27, 2024 in this case. Mr. Shepro received 59,897 shares of common stock in lieu of $71,277 for the third quarter of 2024. The Adjustment was determined by dividing the amount of the forgone cash compensation by $1.19, the closing share price the day immediately preceding the grant date, September 27, 2024 in this case. Mr. Shepro received 99,968 shares of common stock in lieu of $71,277 for the fourth quarter of 2024. The Adjustment was determined by dividing the amount of the forgone cash compensation by $0.713, the closing share price the day immediately preceding the grant date, December 30, 2024 in this case.
(7)
Includes an education allowance, a goods and services allowance, a travel allowance, medical benefits and $104,882 tax gross-up payments on perquisites. Mr. Shepro’s other compensation includes benefits paid in euros and, for purposes of the table, is converted into U.S. dollars based on the Bloomberg one-year average exchange rate ending on December 31, 2024 of 0.9244 euros to the U.S. dollar.
(8)
During 2023, $21,525 of Ms. Esterman’s salary was subject to Adjustment, with the number of shares of common stock granted in lieu of cash determined as follows: Ms. Esterman received 6,046 shares of common stock in lieu of $21,525 for the fourth quarter of 2023. The Adjustment was determined by dividing the amount of the forgone cash compensation by $3.56, the closing share price the day immediately preceding the grant date, December 29, 2023 in this case.
(9)
During 2024, $129,152 of Ms. Esterman’s salary was subject to Adjustment, with the number of shares of common stock granted in lieu of cash determined on a quarterly basis as follows: Ms. Esterman received 16,643 shares of common stock in lieu of $32,288 for the first quarter of 2024. The Adjustment was determined by dividing the amount of the forgone cash compensation by $1.94, the closing share price the day immediately preceding the grant date, March 28, 2024 in this case. Ms. Esterman received 22,738 shares of common stock in lieu of $32,288 for the second quarter of 2024. The Adjustment was determined by dividing the amount of the forgone cash compensation by $1.42, the closing share price the day immediately preceding the grant date, June 27, 2024 in this case. Ms. Esterman received 27,133 shares of common stock in lieu of $32,288 for the third quarter of 2024. The Adjustment was determined by dividing the amount of the forgone cash compensation by $1.19, the closing share price the day immediately preceding the grant date, September 27, 2024 in this case. Ms. Esterman received 45,285 shares of common stock in lieu of $32,288 for the fourth quarter of 2024. The Adjustment was determined by dividing the amount of the forgone cash compensation by $0.713, the closing share price the day immediately preceding the grant date, December 30, 2024 in this case.
(10)
Mr. Ritts’ base salary is set and paid in euros. His base salary was converted to U.S. dollars, for purposes of the table, based on Bloomberg one-year average exchange rate ending on December 31, 2024 of 0.9244 euros to the U.S. dollar.
(11)
Includes housing allowance and a travel allowance paid in euros and, for purposes of the table, is converted into U.S. dollars based on Bloomberg one-year average exchange rate ending on December 31, 2024 of 0.9244 euros to the U.S. dollar.
Narrative Disclosure to Summary Compensation Table
For the year ended December 31, 2024, the compensation program for our Named Executive Officers consisted of base salary, annual incentive compensation, equity awards, other benefits, as well as relocation and foreign living allowances for certain of our Luxembourg-based Named Executive Officers.
Base Salary
The Compensation Committee sets the base salary for our Chief Executive Officer and approves the base salaries for all other Named Executive Officers.
Base salaries are reviewed periodically, and adjustments may be made based on market information, internal review of the Named Executive Officer’s compensation in relation to other executives, individual performance and corporate performance. Salary levels are also considered upon relocation, promotion or change in job responsibility. In addition, base salaries of our Luxembourg-based Named Executive Officers may be subject to inflationary adjustments from time to time as required by applicable Luxembourg law.